Literature DB >> 15094131

Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases.

Nick Di Girolamo1, Jeanie Chui, Minas T Coroneo, Denis Wakefield.   

Abstract

Pterygium is a common ocular surface disease apparently only observed in humans. Chronic UV exposure is a widely accepted aetiological factor in the pathogenesis of this disease and this concept is supported by epidemiological data, ray tracing models and histopathological changes that share common features with UV damaged skin. The mechanism(s) of pterygium formation is incompletely understood. Recent data have provided evidence implicating a genetic component, anti-apoptotic mechanisms, cytokines, growth factors, extracellular matrix remodelling (through the actions of matrix metalloproteinases), immunological mechanisms and viral infections in the pathogenesis of this disease. In this review, the current knowledge on pterygium pathogenesis is summarised, highlighting recent developments. In addition, we provide novel data further demonstrating the complexity of this intriguing disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15094131     DOI: 10.1016/j.preteyeres.2004.02.002

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  91 in total

1.  New approach for pterygium removal using 20 % ethanol.

Authors:  Erez Tsumi; Jaime Levy; Anry Pitchkhadze; Amjad Baidousi; Tova Lifshitz
Journal:  Int Ophthalmol       Date:  2012-06-21       Impact factor: 2.031

2.  [Pterygium. Etiology, clinical aspects and novel adjuvant therapies].

Authors:  L M Heindl; C Cursiefen
Journal:  Ophthalmologe       Date:  2010-06       Impact factor: 1.059

3.  Proliferative and migratory aptitude in pterygium.

Authors:  Haiqing Bai; Yufei Teng; Lee Wong; Vishal Jhanji; Chi-Pui Pang; Gary Hin-Fai Yam
Journal:  Histochem Cell Biol       Date:  2010-10-12       Impact factor: 4.304

4.  Inhibitory effect of PPARγ agonist on the proliferation of human pterygium fibroblasts.

Authors:  Yuan Zou; Mingchang Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-12-22

5.  Pterygium.

Authors:  A S Solomon
Journal:  Br J Ophthalmol       Date:  2006-06       Impact factor: 4.638

6.  Ophthalmic pterygium: a stem cell disorder with premalignant features.

Authors:  Jeanie Chui; Minas T Coroneo; Lien T Tat; Roger Crouch; Denis Wakefield; Nick Di Girolamo
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

7.  Human papillomavirus and pterygium. Is the virus a risk factor?

Authors:  Nicolai Christian Sjö; Christian von Buchwald; Jan Ulrik Prause; Bodil Norrild; Troels Vinding; Steffen Heegaard
Journal:  Br J Ophthalmol       Date:  2006-12-19       Impact factor: 4.638

8.  Inhibition effect of curcumin on UVB-induced secretion of pro-inflammatory cytokines from corneal limbus epithelial cells.

Authors:  Shih-Chun Chao; Dan-Ning Hu; Joan Roberts; Xilun Shen; Chia-Yi Lee; Chan-Wei Nien; Hung-Yu Lin
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

9.  Effect of porcine chondrocyte-derived extracellular matrix on the pterygium in mouse model.

Authors:  Hye Sook Lee; Ji Hyun Lee; Jae Wook Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-02-23       Impact factor: 3.117

10.  Calcium-binding S100 protein expression in pterygium.

Authors:  Andri K Riau; Tina T Wong; Roger W Beuerman; Louis Tong
Journal:  Mol Vis       Date:  2009-02-16       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.